摘要

We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-inducible factor-1 (HIF-1)-active tumors. %26lt;br%26gt;We synthesized the peptide probes that contain or lack an essential sequence of the oxygen-dependent degradation of HIF-1 alpha in proteasomes (I-123/125-DKOP30 or I-125-mDKOP, respectively). The degradation of probes was evaluated in vitro using cell lysates containing proteasomes. In vivo biodistribution study, planar imaging, autoradiography, and comparison between probe accumulation and HIF-1 transcriptional activity were also performed. %26lt;br%26gt;The I-125-DKOP30 underwent degradation in a proteasome-dependent manner, while I-125-mDKOP was not degraded. Biodistribution analysis showed I-125-DKOP30 accumulation in tumors. The tumors were clearly visualized by in vivo imaging, and intratumoral distribution of I-125-DKOP30 coincided with the HIF-1 alpha-positive hypoxic regions. Tumoral accumulation of I-125-DKOP30 was significantly correlated with HIF-1-dependent luciferase bioluminescence, while that of I-125-mDKOP was not. %26lt;br%26gt;I-123-DKOP30 is a useful peptide probe for the imaging of HIF-1-active tumors.

  • 出版日期2013-12